TY - JOUR
T1 - COVID-19 vaccination and changes in the menstrual cycle among vaccinated persons
AU - Farland, Leslie V.
AU - Khan, Sana M.
AU - Shilen, Alexandra
AU - Heslin, Kelly M.
AU - Ishimwe, Providence
AU - Allen, Alicia M.
AU - Herbst-Kralovetz, Melissa M.
AU - Mahnert, Nichole D.
AU - Pogreba-Brown, Kristen
AU - Ernst, Kacey C.
AU - Jacobs, Elizabeth T.
N1 - Publisher Copyright: © 2022 American Society for Reproductive Medicine
PY - 2023/3
Y1 - 2023/3
N2 - Objective: To describe the characteristics of people who experience changes to their menstrual cycle after COVID-19 vaccination. Design: Longitudinal study. Patient(s): We recruited a volunteer sample with and without a history of SARS-CoV-2 infection who enrolled in the Arizona COVID-19 Cohort (CoVHORT) study and participated in a reproductive sub-cohort who were pre-menopausal, not pregnant, and had received a COVID-19 vaccine in 2021 (n = 545). Exposure(s): Demographic and reproductive characteristics were collected via self-reports. Main Outcome Measure(s): Information on self-reported changes in the menstrual cycle after COVID-19 vaccination was collected from May 2021 to December 2021. We looked at demographic and reproductive characteristics as predictors of menstrual cycle change. Result(s): The majority of our vaccinated sample received the Pfizer-BioNTech vaccine (58%), and were 26-35 years old (51%), non-Hispanic (84%), and White (88%). Approximately 25% of vaccinated participants reported a change in their menstrual cycle after vaccination; the majority reported changes after their second dose (56%) as compared with their first (18%) and third (14%) doses. The most commonly reported changes were irregular menstruation (43%), increased premenstrual symptoms (34%), increased menstrual pain or cramps (30%), and abnormally heavy or prolonged bleeding (31%). High self-reported perceived stress levels compared with low perceived stress (OR, 2.22; 95% CI 1.12-4.37) and greater body mass index (OR, 1.04; 95% CI 1.00-1.07) were associated with greater odds of experiencing the menstrual cycle changes after the vaccination. Participants having a history of SARS-CoV-2 infection were less likely to report changes in their menstrual cycle after vaccination compared with the participants with no history of SARS-CoV-2 infection (OR, 0.58; 95% CI 0.32-1.04). Conclusion(s): Among vaccinated participants, approximately 25% of them reported predominantly temporary changes in the menstrual cycle, however, we are unable to determine whether these changes are due to normal cycle variability. The COVID-19 vaccines are safe and effective for everyone, including pregnant people and people trying to conceive; hence, these findings should not discourage vaccination.
AB - Objective: To describe the characteristics of people who experience changes to their menstrual cycle after COVID-19 vaccination. Design: Longitudinal study. Patient(s): We recruited a volunteer sample with and without a history of SARS-CoV-2 infection who enrolled in the Arizona COVID-19 Cohort (CoVHORT) study and participated in a reproductive sub-cohort who were pre-menopausal, not pregnant, and had received a COVID-19 vaccine in 2021 (n = 545). Exposure(s): Demographic and reproductive characteristics were collected via self-reports. Main Outcome Measure(s): Information on self-reported changes in the menstrual cycle after COVID-19 vaccination was collected from May 2021 to December 2021. We looked at demographic and reproductive characteristics as predictors of menstrual cycle change. Result(s): The majority of our vaccinated sample received the Pfizer-BioNTech vaccine (58%), and were 26-35 years old (51%), non-Hispanic (84%), and White (88%). Approximately 25% of vaccinated participants reported a change in their menstrual cycle after vaccination; the majority reported changes after their second dose (56%) as compared with their first (18%) and third (14%) doses. The most commonly reported changes were irregular menstruation (43%), increased premenstrual symptoms (34%), increased menstrual pain or cramps (30%), and abnormally heavy or prolonged bleeding (31%). High self-reported perceived stress levels compared with low perceived stress (OR, 2.22; 95% CI 1.12-4.37) and greater body mass index (OR, 1.04; 95% CI 1.00-1.07) were associated with greater odds of experiencing the menstrual cycle changes after the vaccination. Participants having a history of SARS-CoV-2 infection were less likely to report changes in their menstrual cycle after vaccination compared with the participants with no history of SARS-CoV-2 infection (OR, 0.58; 95% CI 0.32-1.04). Conclusion(s): Among vaccinated participants, approximately 25% of them reported predominantly temporary changes in the menstrual cycle, however, we are unable to determine whether these changes are due to normal cycle variability. The COVID-19 vaccines are safe and effective for everyone, including pregnant people and people trying to conceive; hence, these findings should not discourage vaccination.
KW - COVID-19 vaccination
KW - SARS-CoV-2
KW - menstrual cycle
KW - menstrual regularity
UR - http://www.scopus.com/inward/record.url?scp=85147553145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147553145&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2022.12.023
DO - 10.1016/j.fertnstert.2022.12.023
M3 - Article
C2 - 36539055
SN - 0015-0282
VL - 119
SP - 392
EP - 400
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 3
ER -